^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    BMS-986406

    i
    Other names: BMS-986406, ONO-7226
    Associations

    News

    Trials
    Company:
    BMS, Ono Pharma
    Drug class:
    ILT-4 inhibitor
    Related drugs:
    Associations

    News

    Trials
    9d
    A Study of BMS-986406 as Monotherapy and Combination Therapies in Participants With Advanced Tumors (clinicaltrials.gov)
    P1, N=154, Active, not recruiting, Bristol-Myers Squibb | Recruiting --> Active, not recruiting
    Enrollment closed • Combination therapy • Metastases
    |
    Opdivo (nivolumab) • carboplatin • paclitaxel • pemetrexed • BMS-986406
    1year
    A Study of BMS-986406 as Monotherapy and Combination Therapies in Participants With Advanced Tumors (clinicaltrials.gov)
    P1, N=154, Recruiting, Bristol-Myers Squibb | N=112 --> 154
    Enrollment change • Combination therapy • Metastases
    |
    Opdivo (nivolumab) • carboplatin • paclitaxel • pemetrexed • BMS-986406